73,833 Shares in Cigna Group $CI Bought by Kiltearn Partners LLP

Kiltearn Partners LLP purchased a new position in shares of Cigna Group (NYSE:CI) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 73,833 shares of the health services provider’s stock, valued at approximately $20,354,000. Cigna Group makes up approximately 4.9% of Kiltearn Partners LLP’s holdings, making the stock its 7th largest holding.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Haverford Trust Co bought a new position in shares of Cigna Group during the 2nd quarter worth about $629,000. Clear Harbor Asset Management LLC bought a new stake in Cigna Group in the second quarter valued at about $626,000. First Nebraska Trust Co acquired a new position in Cigna Group in the second quarter worth about $211,000. Bank of Nova Scotia bought a new position in Cigna Group during the second quarter worth about $73,764,000. Finally, Welch Capital Partners LLC NY bought a new position in Cigna Group during the second quarter worth about $462,000. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider directly owned 27,256 shares in the company, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 23,012 shares of company stock valued at $6,386,550. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Price Performance

Shares of Cigna Group stock opened at $276.19 on Friday. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $72.98 billion, a price-to-earnings ratio of 11.43, a P/E/G ratio of 0.95 and a beta of 0.29. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47. The firm’s 50-day moving average price is $284.20 and its two-hundred day moving average price is $281.38.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same quarter last year, the business posted $7.20 earnings per share. The company’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts predict that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Wall Street Analysts Forecast Growth

CI has been the topic of several analyst reports. Barclays upped their price objective on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Piper Sandler cut their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research report on Wednesday, June 3rd. Royal Bank Of Canada boosted their price target on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research note on Friday, May 1st. Wall Street Zen cut Cigna Group from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Finally, Guggenheim increased their price objective on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.